Larson Financial Group’s Protara Therapeutics TARA Stock Holding History

Larson Financial Group’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$18.6K	Buy	+6,105	New	+$23.8K	﹤0.01%	2156

Other funds holding TARA

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Indivisible Partners Clearwater, Florida $2.18B AUM 33.61% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Larson Financial Group's TARA Position: Q3 2026 in Review

Larson Financial Group opened a new position in Protara Therapeutics (TARA) in Q3 2026: 6,105 shares worth $18.6K. The stake represents ﹤0.01% of the portfolio and ranks #2156 among its holdings.

28 funds tracked by Wall St. Rank hold TARA as of Q3 2026.

Larson Financial Group held 6,105 shares of Protara Therapeutics worth $18.6K as of Q3 2026.
Protara Therapeutics was a new Larson Financial Group position in Q3 2026.
Protara Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2156 holding.
28 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.